Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals - Wikidata - awgldk - TriplyDB

Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals

Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals

http://www.wikidata.org/entity/Q33595408

about

Pathogenesis of human immunodeficiency virus infection Human immunodeficiency virus type 1 and mucosal humoral defense.P24 antigen detection, viral isolation, DNA-PCR and in vitro antibody production for the diagnosis of HIV-1 latent infection in heterosexual women at high risk for HIV-1 infection Alternative routes of mucosal immunization in large animals.Detection of occult simian immunodeficiency virus SIVsmm infection in asymptomatic seronegative nonhuman primates and evidence for variation in SIV gag sequence between in vivo- and in vitro-propagated virus.Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats.Development of oligonucleotide primers and probes against structural and regulatory genes of human immunodeficiency virus type 1 (HIV-1) and their use for amplification of HIV-1 provirus by using polymerase chain reaction Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus Human immunodeficiency virus (HIV-1) seropositivity among children in a rural population of south-west Uganda: probable routes of exposure.Retroviruses and the pathogenesis of systemic sclerosis.Detecting seronegative-early HIV infections among adult versus student Kenyan blood donors, by using Stimmunology.Infection of simian B lymphoblastoid cells with simian immunodeficiency virus is associated with upregulation of CD23 and CD40 cell surface markers.Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA.

P2860

Q24634681-B41CCEB9-1BED-4A78-90AE-31A31A7DA564 Q33547162-86BE3EA9-D4CF-45B0-9073-E6923E23B6B3 Q33935582-535F225F-B0C4-46F7-9286-1CF812F45A5F Q35675891-74C64EE2-BCEB-4BD2-BC65-58588C4CDAD0 Q36683910-523B5749-30AC-4BAF-A6FA-BE7601946CA0 Q36698696-811D8783-23BF-4B37-8FE0-FD40F7CF9AF8 Q37126356-38825238-5D13-40B9-A00F-13E5D99B6002 Q37375345-F2D5DEEB-C604-4F90-9917-BFE2330689A2 Q38888887-17462E12-B614-41B9-AB82-B7DA5BD81B5E Q40468530-3B294216-8E3D-4BCB-BD72-D84F734ECA2E Q43527701-1F9F5983-D818-439E-9F19-8E2F1E690720 Q45731070-88D24F09-C155-48F6-B6CE-2BA547C31687 Q45757699-8A8D9A74-DEFE-4718-A721-FE1DE8EB8917

P2860

Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals

http://www.wikidata.org/entity/Q33595408

description

1990 nî lūn-bûn

@nan

1990 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

Polyclonal B-cell activation r ...... HIV-1-seronegative individuals

@ast

Polyclonal B-cell activation r ...... HIV-1-seronegative individuals

@en

type

label

Polyclonal B-cell activation r ...... HIV-1-seronegative individuals

@ast

Polyclonal B-cell activation r ...... HIV-1-seronegative individuals

@en

prefLabel

Polyclonal B-cell activation r ...... HIV-1-seronegative individuals

@ast

Polyclonal B-cell activation r ...... HIV-1-seronegative individuals

@en

P1433

Q33595408-887F090C-CDDF-4A5E-BE7D-59B945F1C571

P1476

Q33595408-DA21386C-B944-4559-9CB4-5D0E07E0F2F1

P2093

Q33595408-13B9CA7F-C255-4AC4-BB01-591D1ACFC9AC

Q33595408-18B22DC4-61FA-4348-A048-A46FCDDB1194

Q33595408-273E141D-3E37-4072-816F-047B853FBBCD

Q33595408-53A63E47-74D4-49C7-B8B7-B380D90DB2A8

Q33595408-8A033E13-E58B-47CE-8DCB-F488900590B0

Q33595408-99430D02-B62F-4851-9FE2-5FF95145F9D8

Q33595408-B891EA57-7655-4CAC-B780-F758634B1584

Q33595408-F3A43CAB-27BD-483E-9600-1A9CE837AFF2

Q33595408-F888F13C-57B3-4419-B97A-2A644ADDBD84

P2860

Q33595408-0BD2445B-07AA-46BF-9BA8-1C33A364C809

Q33595408-1EAFFCCF-6124-47EC-B857-E8EE6E175411

Q33595408-2A2CBCD8-C1DA-415B-B6E1-F8CDA2EAEE6C

Q33595408-49335DB4-1579-45E9-9FA1-75E30D6FD04C

Q33595408-73FE8723-6669-4226-9999-DEF6EA8CAA61

Q33595408-C1ADAFB2-55EB-4AF0-94E1-4DD30C2577E4

Q33595408-C83FF64C-1716-4A31-9522-FB7C06994F47

Q33595408-D48C9905-FD41-4758-91C9-DCAD3D615729

Q33595408-D7CF1B38-3FE8-4AD8-82D5-0BE991D80403

Q33595408-E8D85D81-E078-4AC6-B6F3-35C8586E3669

P304

Q33595408-77EB3104-CCAF-47B5-8EA3-4DC377D83EDA

P31

Q33595408-5C4CAF32-4EA8-4DA9-96DD-1765D445389B

P356

Q33595408-75AB8F8C-F76C-4957-84F0-43B91370F04F

P407

Q33595408-60084AB8-F6F7-4AD1-8D15-C8542B60C436

P433

Q33595408-F4F2E38B-AD57-4D5D-9CB0-90AF4F987F6A

P478

Q33595408-ABDDAFF1-5000-4FD1-9D74-72CD52AAEE4E

P577

Q33595408-169988B3-1A40-419F-AB1C-683688163ACE

P5875

Q33595408-9065552D-C88A-4B07-B867-F485554B7196

P698

Q33595408-693286B9-83A7-45DB-B752-E0A925456474

P932

Q33595408-62A5222F-4FFF-408F-940B-BE9B8B30BF37

P356

PNAS.87.10.3972

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Polyclonal B-cell activation r ...... HIV-1-seronegative individuals

@en

P2093

A Ahmed-Ansari

http://www.w3.org/2001/XMLSchema#string

B A Slade

http://www.w3.org/2001/XMLSchema#string

B De

http://www.w3.org/2001/XMLSchema#string

F Villinger

http://www.w3.org/2001/XMLSchema#string

H M McClure

http://www.w3.org/2001/XMLSchema#string

J D Powell

http://www.w3.org/2001/XMLSchema#string

K W Sell

http://www.w3.org/2001/XMLSchema#string

T Jehuda-Cohen

http://www.w3.org/2001/XMLSchema#string

T M Folks

http://www.w3.org/2001/XMLSchema#string

P2860

The role of mononuclear phagocytes in HTLV-III/LAV infection

B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters.

AIDS: a syndrome of immune dysregulation, dysfunction, and deficiency.

Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role

Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen.

Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations.

Soluble antigen abrogates the appearance of anti-protein IgG1-forming cell precursors during primary immunization.

Mechanisms of clonal abortion tolerogenesis. I. Response of immature hapten-specific B lymphocytes.

Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies.

Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men.

P304

3972-3976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.87.10.3972

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

1990-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21045057

http://www.w3.org/2001/XMLSchema#string

P698

2111024

http://www.w3.org/2001/XMLSchema#string

P932

54026

http://www.w3.org/2001/XMLSchema#string